Cargando…
2120. Respiratory Viral Infections in Patients with Hematologic Malignancies
BACKGROUND: Respiratory virus infections (RVI) are an important cause of pneumonia with increased risk of morbidity and mortality in patients with hematologic malignancies (HM) especially after stem cell transplantation. However, data on RVI in this population without stem cell transplant is still l...
Autores principales: | Cardenas, Jorge Luis, Raja, Mohammed, Camargo, Jose F, Morris, Michele I, Natori, Yoichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752989/ http://dx.doi.org/10.1093/ofid/ofac492.1741 |
Ejemplares similares
-
2709. Breakthrough fungal infection after isavuconazole primary prophylaxis in patients with hematologic malignancy and hematopoietic stem cell transplant: Systematic Review
por: Ishida, Keiko, et al.
Publicado: (2023) -
PB2120: HIV AND MALIGNANT HEMOPATHIES
por: Khibri, H., et al.
Publicado: (2022) -
Discordance Between Radiologic Findings and Molecular Testing in Patients With Underlying Hematologic Malignancy and Coronavirus Disease 2019
por: Raja, Mohammed, et al.
Publicado: (2020) -
1103. Respiratory Virus Infections In Solid Organ Transplant Recipients: A Single Center Experience
por: Mendoza, Maria A, et al.
Publicado: (2020) -
1119 Respiratory Viral Infections in a Cohort of Patients with Hematological Malignancies
por: Vilar-Compte, Diana, et al.
Publicado: (2014)